Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
Research & Development
Teva Pharmaceutical Industries Ltd
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Research & Development
-$953m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Research & Development
-$60.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Research & Development
-₪550k
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
Mediwound Ltd
NASDAQ:MDWD
|
Research & Development
-$7.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-7%
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Research & Development
-₪3.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Research & Development
-₪2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Research & Development?
Research & Development
-953m
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Research & Development amounts to -953m USD.
What is Teva Pharmaceutical Industries Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
4%
Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for Teva Pharmaceutical Industries Ltd have been 1% over the past three years , 5% over the past five years , and 4% over the past ten years .